These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 18584938

  • 21. A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase.
    An J, Lee DC, Law AH, Yang CL, Poon LL, Lau AS, Jones SJ.
    J Med Chem; 2009 May 14; 52(9):2667-72. PubMed ID: 19419201
    [Abstract] [Full Text] [Related]

  • 22. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.
    Ilyushina NA, Hoffmann E, Salomon R, Webster RG, Govorkova EA.
    Antivir Ther; 2007 May 14; 12(3):363-70. PubMed ID: 17591026
    [Abstract] [Full Text] [Related]

  • 23. Dynamic behavior of avian influenza A virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues.
    Udommaneethanakit T, Rungrotmongkol T, Bren U, Frecer V, Stanislav M.
    J Chem Inf Model; 2009 Oct 14; 49(10):2323-32. PubMed ID: 19780597
    [Abstract] [Full Text] [Related]

  • 24. Computational studies of H5N1 influenza virus resistance to oseltamivir.
    Wang NX, Zheng JJ.
    Protein Sci; 2009 Apr 14; 18(4):707-15. PubMed ID: 19309695
    [Abstract] [Full Text] [Related]

  • 25. Selective binding of antiinfluenza drugs and their analogues to 'open' and 'closed' conformations of H5N1 neuraminidase.
    Wang P, Zhang JZ.
    J Phys Chem B; 2010 Oct 14; 114(40):12958-64. PubMed ID: 20860351
    [Abstract] [Full Text] [Related]

  • 26. H274Y's Effect on Oseltamivir Resistance: What Happens Before the Drug Enters the Binding Site.
    Yusuf M, Mohamed N, Mohamad S, Janezic D, Damodaran KV, Wahab HA.
    J Chem Inf Model; 2016 Jan 25; 56(1):82-100. PubMed ID: 26703840
    [Abstract] [Full Text] [Related]

  • 27. On the lower susceptibility of oseltamivir to influenza neuraminidase subtype N1 than those in N2 and N9.
    Aruksakunwong O, Malaisree M, Decha P, Sompornpisut P, Parasuk V, Pianwanit S, Hannongbua S.
    Biophys J; 2007 Feb 01; 92(3):798-807. PubMed ID: 17085491
    [Abstract] [Full Text] [Related]

  • 28. A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1.
    Duwe S, Schweiger B.
    J Virol Methods; 2008 Nov 01; 153(2):134-41. PubMed ID: 18725246
    [Abstract] [Full Text] [Related]

  • 29. The significance of naturally occurring neuraminidase quasispecies of H5N1 avian influenza virus on resistance to oseltamivir: a point of concern.
    Schaduangrat N, Phanich J, Rungrotmongkol T, Lerdsamran H, Puthavathana P, Ubol S.
    J Gen Virol; 2016 Jun 01; 97(6):1311-1323. PubMed ID: 26935590
    [Abstract] [Full Text] [Related]

  • 30. [Analysis of decrease in sensitivity in influenza A (H5N1) avian and human strains to neuraminidase inhibitors].
    Reina J.
    Rev Esp Quimioter; 2008 Mar 01; 21(1):32-6. PubMed ID: 18443931
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Insight into the oseltamivir resistance R292K mutation in H5N1 influenza virus: a molecular docking and molecular dynamics approach.
    Karthick V, Ramanathan K.
    Cell Biochem Biophys; 2014 Mar 01; 68(2):291-9. PubMed ID: 23794010
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Inhibition of viral group-1 and group-2 neuraminidases by oseltamivir: A comparative structural analysis by the ScrewFit algorithm.
    Calligari PA, Kneller GR, Giansanti A, Ascenzi P, Porrello A, Bocedi A.
    Biophys Chem; 2009 Apr 01; 141(1):117-23. PubMed ID: 19195766
    [Abstract] [Full Text] [Related]

  • 35. Study of Tamiflu sensitivity to variants of A/H5N1 virus using different force fields.
    Nguyen TT, Mai BK, Li MS.
    J Chem Inf Model; 2011 Sep 26; 51(9):2266-76. PubMed ID: 21834591
    [Abstract] [Full Text] [Related]

  • 36. A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A/H3N2 virus.
    Abed Y, Baz M, Boivin G.
    J Infect Dis; 2009 Jan 15; 199(2):180-3. PubMed ID: 19046066
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Rational design of Tamiflu derivatives targeting at the open conformation of neuraminidase subtype 1.
    Li Y, Zhou B, Wang R.
    J Mol Graph Model; 2009 Oct 15; 28(3):203-19. PubMed ID: 19656699
    [Abstract] [Full Text] [Related]

  • 39. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2009 Sep 11; 58(35):969-72. PubMed ID: 19745803
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.